Amgen
AMGN
#101
Rank
NZ$257.48 B
Marketcap
$479.02
Share price
-5.28%
Change (1 day)
6.52%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$12.86 Billion

According to Amgen's latest financial reports the company has NZ$12.86 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Amgen - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$9.85 B70.9%
2022-12-31$NZ$5.76 B-41.21%
2021-12-31$NZ$9.80 B-24.78%
2020-12-31$NZ$13.04 B-9.21%
2019-12-31$NZ$14.36 B-22.93%
2018-12-31$NZ$18.63 B-47.57%
2017-12-31$NZ$35.54 B-17.59%
2016-12-31$NZ$43.12 B5.11%
2015-12-31$NZ$41.03 B24.72%
2014-12-31$NZ$32.90 B22.36%
2013-12-31$NZ$26.88 B16.05%
2012-12-31$NZ$23.16 B-4.97%
2011-12-31$NZ$24.38 B-21.44%
2010-12-31$NZ$31.03 B-0.55%
2009-12-31$NZ$31.20 B-11.16%
2008-12-31$NZ$35.12 B50.59%
2007-12-31$NZ$23.32 B-13.34%
2006-12-31$NZ$26.91 B-10.04%
2005-12-31$NZ$29.92 B8.35%
2004-12-31$NZ$27.61 B-7.41%
2003-12-31$NZ$29.82 B-14.63%
2002-12-31$NZ$34.94 B178.1%
2001-12-31$NZ$12.56 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$158.17 B 1,129.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.39 B 128.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.76 B 139.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$31.09 B 141.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$27.95 B 117.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.37 B-19.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$119.89 B 832.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.63 B-71.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.47 B 90.26%๐Ÿ‡บ๐Ÿ‡ธ USA